Login
Navigate Fool.com
Will MSTX beat
the market?

Mast Therapeutics, Inc.

NYSEMKT: MSTX

Community Rating: 3 Stars: Appealing

0.56 0.01 (1.80%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.55
Previous Close $0.55
Daily Range $0.54 - $0.58
52-Week Range $0.40 - $1.10
Market Cap $63.6M
P/E Ratio -2.00
Dividend (Yield) $0.00 (0.0%)
Volume 934,008
Average Daily Volume 2,704,675
Current FY EPS -$0.29

How do you think MSTX
will perform against the market?

Top MSTX Bull/Bear Pitches

 

TSIF (< 20)
Submitted November 17, 2011

I caught Adventrx Pharmaceuticals, Inc plunging like a rock on November 11th and I stopped in to see if my favorite CAPS bio followers had rated it. ZZlangerhans had just given it one of his speculat … More

4 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted June 28, 2011

I reached out to Adventrx about a year ago, seeing multibagger Bottle Imp potential based on their early 2010 performance after the initial Exelbine NDA submission. I gave up on the pick two months ag … More

0 Replies Reply Report this Post

News & Commentary

The Big Bet on YM BioSciences

Playing catch-up in myelofibrosis.

Four Biotech Names with Major Market Potential: Michael Higgins

ADVENTRX Files To Raise Capital (ANX)

Zacks #1 Rank Additions for Monday - Tale of the Tape

Blue Horseshoe - Or Someone - Likes Anaconda Mining; Shares Pop 20% After Selling Iron Ore Assets

Zacks #1 Rank Additions for Friday - Tale of the Tape

Zacks #1 Rank Additions for Friday - Tale of the Tape

Speedy in Seattle

Seattle Genetics gets an early approval of Adcentris.

5 of Last Week's Biggest Losers

These five stocks made shorts a lot of money last week.

Aeterna Zentaris: Out of Sight, Out of Mind

Perifosine, the company's lead cancer drug, hits key milestones.

Adventrx Plunges Almost 60% on Botched Drug Study

CEO Culley says the company's lead drug candidate, Exelbine for lung cancer, may be sold.

See More MSTX News...

Sector

Healthcare

Industry

Drugs

Mast Therapeutics, Inc. (MSTX) Description

A biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases. Website: http://www.masttherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks